Physician profile
Amy Lockhert
NPI 1265420293
$1,294.98
in general payments reported to CMS, 2019-2025
23 companies · $693 in 2025
The $693 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $255 · 2020: $20.34 · 2021: $239 · 2024: $88.24 · 2025: $693.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $736 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $735.98 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $199.04 | 2025 | Mounjaro, Jardiance |
| Abbvie INC. | $135.54 | 2021-2025 | |
| Amgen INC. | $93.67 | 2025 | Repatha, Otezla, Evenity |
| Collegium Pharmaceutical, INC. | $93.54 | 2019-2025 | Jornay Pm |
| Integra Lifesciences Corporation | $89.07 | 2019 | |
| Abbott Laboratories | $80.89 | 2021-2025 | Freestyle Libre |
| Biodelivery Sciences International, INC. | $73.34 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.29 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $57.59 | 2025 | Breztri, Farxiga |
| Sanofi Pasteur INC. | $53.26 | 2025 | |
| Novo Nordisk INC | $51.16 | 2025 | Wegovy |
| Glaxosmithkline, LLC. | $49.13 | 2020-2025 | Shingrix, Arexvy, Bexsero |
| Grt US Holding, INC. | $45.00 | 2021 | |
| Emergent Biosolutions INC. | $45.00 | 2021 | |
| Dexcom, INC. | $25.95 | 2025 | Dexcom G6 Transmitter |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $22.11 | 2025 | Puraply Wound Matrix |
| Z-Medica, LLC | $20.65 | 2019 | |
| Viatris Specialty LLC | $20.05 | 2025 | Yupelri |
| Exact Sciences Corporation | $18.82 | 2025 | The Cologuard Plus Collection Kit |
| Phathom Pharmaceuticals, INC. | $17.26 | 2025 | Voquezna |
| Kerecis Limited | $16.93 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Apria Healthcare LLC | $13.85 | 2021 | |
| Janssen Pharmaceuticals, INC | $13.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Lockhert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.